Here is how a cat can hinder children learning new words

Say you are shown an apple, a banana and a fruit you have never seen before. Then you are asked to pick the “pifo.” Which fruit would you choose? Chances are you would select the novel fruit. Children often use the same strategy—leveraging their knowledge of familiar objects—to learn new words and connect them with

New compound helps activate cancer-fighting T cells: Study identifies mechanisms responsible for improved immune system activity, offering new approaches for more effective cancer treatments and vaccines.

Invariant natural killer T (iNKT) cells are powerful weapons our body’s immune systems count on to fight infection and combat diseases like cancer, multiple sclerosis, and lupus. Finding ways to spark these potent cells into action could lead to more effective cancer treatments and vaccines. While several chemical compounds have shown promise stimulating iNKT cells

Vanderbilt creates AI and natural language processing voice assistant for its Epic EHR

Vanderbilt University Medical Center has developed a voice assistant for caregivers to use navigating the hospital's Epic electronic health record. The new tool processes requests using natural language processing and understanding technology, and not just macros, officials say – noting that it could represent an important paradigm shift in how providers interact with their EHRs

Monitor detects dangerously low white blood cell levels: Technology could help prevent life-threatening infections in patients receiving chemotherapy

One of the major side effects of chemotherapy is a sharp drop in white blood cells, which leaves patients vulnerable to dangerous infections. MIT researchers have now developed a portable device that could be used to monitor patients’ white blood cell levels at home, without taking blood samples. Such a device could prevent thousands of

Sure, cancer mutates, but it has other ways to resist treatment

Because of advances in drug design and precision medicine, researchers have been able to target certain molecules within a cell at the root of a particular disease and to develop specific therapies to undo their damages. Today, precision targeting combines therapy decisions with molecular insights to offer hope after a life-changing cancer diagnosis. But there’s

Taming an unruly target in diabetes

Focusing on a simple hormone in us all, a Yale researcher has found specific forms of it that poke toxic holes in cells—a discovery that he is leveraging into a treatment for patients with diabetes. The research, published April 3 in Nature Communications, is also central to the recent awarding of two grants totaling $600,000

Smartphone app performs better than traditional exam in cardiac assessment: Randomized clinical trial

A smartphone application using the phone’s camera function performed better than traditional physical examination to assess blood flow in a wrist artery for patients undergoing coronary angiography, according to a randomized trial published in CMAJ (Canadian Medical Association Journal). These findings highlight the potential of smartphone applications to help physicians make decisions at the bedside.

Considering an employee for an overseas assignment? Study says personality has a big impact on how well they adjust

More globalization means more multinational corporations are increasingly sending their employees overseas, swelling the ranks of expatriates in foreign locales where they are strangers to the language, the culture and ways of doing business. A new study from Florida Atlantic University shows that expatriates’ personality characteristics have a lot to do with how well they

Energy-based devices work well for feminine rejuvenation

(HealthDay)—Energy-based devices are both safe and effective methods of nonsurgical treatment for feminine rejuvenation, according to a review published online March 10 in the Journal of Cosmetic Dermatology. Michael Gold, M.D., from the Gold Skin Care Center in Nashville, Tenn., and colleagues conducted a literature review to explore the safety, efficacy, tolerability, patient satisfaction, and

Outcomes-based pricing doesn’t cut costs of PCSK9 inhibitors

(HealthDay)—Outcomes-based pricing does not reduce the costs of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, according to a research letter published online April 3 in the Annals of Internal Medicine. Dhruv S. Kazi, M.D., from the University of California in San Francisco, and colleagues examined the effect of outcomes-based pricing on the cost-effectiveness of PCSK9